Sharkey article cited in Supreme Court opinion

In her dissent in Riegel v. Medtronic, Justice Ruth Bader Ginsburg cited Catherine Sharkey's article "Federalism in Action: FDA Regulatory Preemption in Pharmaceutical Cases in State Versus Federal Courts" to support the proposition that even though most states do not regard regulatory compliance as dispositive, it is a factor that may be taken into account by the jury, and a manufacturer in those states could present the FDA's approval of its medical device as evidence that it used due care in the design and labeling of the
product. However, Justice Ginsburg wrote that the Court's broad reading of the statute at issue saves the manufacturer from any need to urge such a defense.

Read the Supreme Court opinion for Riegel v. Medtronic

Read Catherine Sharkey's article

Watch video of an AEI panel at which Sharkey discussed federal preemption of state law

Read the Washington Post's coverage of the Riegel ruling

 

Support NYU Law

We are at the forefront of legal education, and with your help we can continue the remarkable transformation that has brought us to this point.

Support NYU Law

Site Seeing

Looking for more? Try these pages:

About NYU Law
Blogs and Journals
Law School Magazine
Milbank Tweed Forum

Click to see more:
Expand